You are here

Our science / Clinical Trials / Find a Trial / NCT01161472

A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects

Back to Search Print Save as PDF Bookmark Trial

NCT01161472

Last updated on February 20, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Overland Park, Kansas, 66211 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
65-85 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Adult healthy volunteers 65 years and over with minimum MMSE of 26

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Prohibited concomitant medications

- Confounding medical conditions

- Clinically significant comorbid diseases

- Hypersensitivity or contraindications to fesoterodine or active control

NCT01161472
Pfizer
Completed
A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Healthy
A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions
NCT02201511
All Genders
18+
Years
Brussels,
Healthy
Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991)
NCT01918176
All Genders
18+
Years
South Miami, Florida
Healthy
A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects
NCT01140672
All Genders
18+
Years
New Haven, Connecticut
Healthy
Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571
NCT03092232
All Genders
18+
Years
New Haven, Connecticut

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now